Security
Lifecore Biomedical, Inc. Common Stock · LFCR
LFCRNASDAQCommon stockCurrentCIK 1005286Updated Nov 17, 2026
LFCR price & chart
Loading TradingView…
NASDAQ:LFCR on TradingView ↗About the company
Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com. The contents of Lifecore’s website are not incorporated by reference into this press release.
In the news
Pomerantz LLP and The Rosen Law Firm, P.A. Announce Proposed Class Action Settlement on Behalf of Purchasers of Lifecore Biomedical, Inc. Securities - LFCR ↗
HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS News provided by Halper Sadeh LLP Jan 29, 2026, 17:09 ET Share this article Share to X Share this article Share to X Shareholders should contact the firm immediately as there may be limited ↗
Recent filings
DEFM14A filing
DEFA14A filing
Other Events
Items 8.01
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
Show 5 more recent filings
PREM14A filing
Other Events
Items 8.01
Entry into a Material Definitive Agreement
Items 1.01, 9.01
DEFA14A filing
Entry into a Material Definitive Agreement · Regulation FD Disclosure
Items 1.01, 7.01, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 237,693,000Source | 246,241,000Source | 232,177,000Source | 255,386,000Source | 245,816,000Source | 235,204,000Source | 246,824,000Source | 245,620,000Source | 232,177,000Source | 253,960,000Source | 236,656,000Source | 277,806,000Source |
| Property, Plant and Equipment, NetUSD | 128,223,000Source | 145,367,000Source | 127,304,000Source | 150,576,000Source | 142,913,000Source | 128,575,000Source | 148,756,000Source | 136,259,000Source | 127,304,000Source | 148,598,000Source | 126,326,000Source | 118,531,000Source |
| GoodwillUSD | 13,881,000Source | 13,881,000Source | 13,881,000Source | 13,881,000Source | 13,881,000Source | 13,881,000Source | 13,881,000Source | 13,881,000Source | 13,881,000Source | 13,881,000Source | 13,881,000Source | 13,881,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 4,200,000Source | 4,200,000Source | — | 4,200,000Source | 4,200,000Source | 4,200,000Source | 4,200,000Source | 4,200,000Source | — | 4,200,000Source | — | — |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 5,417,000Source | — | 17,469,000Source | 9,455,000Source | — | 18,856,000Source | — | — | 17,469,000Source | 8,462,000Source | 2,950,000Source | 1,643,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | — | — | — | 30,303,000Source | — | — | 25,145,000Source | — | — | 31,153,000Source | 30,974,000Source | 48,172,000Source |
| Inventory, NetUSD | 34,596,000Source | 39,670,000Source | 29,085,000Source | 39,214,000Source | 41,446,000Source | 33,801,000Source | 41,642,000Source | 41,690,000Source | 29,085,000Source | 39,979,000Source | 42,042,000Source | 66,845,000Source |
| Assets, CurrentUSD | 84,211,000Source | 76,157,000Source | 82,292,000Source | 81,858,000Source | 76,714,000Source | 83,928,000Source | 74,183,000Source | 82,814,000Source | 82,292,000Source | 81,033,000Source | 83,126,000Source | 123,712,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 2,548,000Source | 1,969,000Source | 1,921,000Source | 2,886,000Source | 1,845,000Source | 2,138,000Source | 1,876,000Source | 5,865,000Source | 1,921,000Source | 1,439,000Source | 1,473,000Source | 7,052,000Source |
| Operating Lease, Right-of-Use AssetUSD | 2,233,000Source | 2,510,000Source | — | 2,304,000Source | 4,036,000Source | — | 2,373,000Source | 4,159,000Source | — | 2,442,000Source | 5,100,000Source | 8,580,000Source |
| Other Assets, NoncurrentUSD | 4,945,000Source | 4,126,000Source | 8,700,000Source | 2,567,000Source | 4,072,000Source | 4,620,000Source | 3,431,000Source | 4,307,000Source | 8,700,000Source | 3,806,000Source | 2,699,000Source | 3,002,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 190,267,000Source | 186,807,000Source | 198,117,000Source | 195,626,000Source | 203,471,000Source | 198,418,000Source | 207,321,000Source | 219,066,000Source | 198,117,000Source | 200,058,000Source | 163,100,000Source | 187,109,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 37,000Source | 30,000Source | 37,000Source | 37,000Source | 30,000Source | 37,000Source | 31,000Source | 30,000Source | 37,000Source | 30,000Source | 30,000Source | 30,000Source |
| Additional Paid in CapitalUSD | 206,285,000Source | 177,096,000Source | 208,962,000Source | 206,868,000Source | 176,463,000Source | 207,521,000Source | 178,784,000Source | 175,700,000Source | 208,962,000Source | 177,808,000Source | 174,243,000Source | 167,352,000Source |
| Retained Earnings (Accumulated Deficit)USD | -204,093,000Source | -159,440,000Source | -223,201,000Source | -191,456,000Source | -175,072,000Source | -218,095,000Source | -182,753,000Source | -189,290,000Source | -223,201,000Source | -166,523,000Source | -139,252,000Source | -76,099,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | — | — | — | — | — | — | — | — | — | — | — | -586,000Source |
| Stockholders' Equity Attributable to ParentUSD | 2,229,000Source | 17,686,000Source | -14,202,000Source | 15,449,000Source | 1,421,000Source | -10,537,000Source | -3,939,000Source | -13,560,000Source | -14,202,000Source | 11,315,000Source | 35,021,000Source | 90,697,000Source |
| Liabilities and EquityUSD | 237,693,000Source | 246,241,000Source | 232,177,000Source | 255,386,000Source | 245,816,000Source | 235,204,000Source | 246,824,000Source | 245,620,000Source | 232,177,000Source | 253,960,000Source | 236,656,000Source | 277,806,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 31,116,000Source | 36,810,000Source | 23,573,000Source | 35,290,000Source | 40,254,000Source | 29,958,000Source | 40,523,000Source | 35,414,000Source | 23,573,000Source | 38,872,000Source | 37,401,000Source | 176,810,000Source |
| Operating Lease, Liability, CurrentUSD | 3,966,000Source | — | — | — | — | 368,000Source | — | — | 372,000Source | 3,962,000Source | — | 1,743,000Source |
| Accounts Payable, CurrentUSD | 7,405,000Source | 15,685,000Source | 6,211,000Source | 14,967,000Source | 19,023,000Source | 10,115,000Source | 18,010,000Source | 15,691,000Source | 5,839,000Source | 16,334,000Source | 14,657,000Source | 15,802,000Source |
| Operating Lease, Liability, NoncurrentUSD | 1,436,000Source | — | — | — | — | 1,214,000Source | — | — | 1,120,000Source | 1,729,000Source | — | 9,971,000Source |
| Deferred Income Tax Liabilities, NetUSD | — | 607,000Source | — | 552,000Source | 416,000Source | — | 443,000Source | 456,000Source | — | 543,000Source | 80,000Source | 126,000Source |
| Other Liabilities, NoncurrentUSD | 9,806,000Source | 5,053,000Source | 6,698,000Source | 5,153,000Source | 183,000Source | 7,965,000Source | 5,114,000Source | 219,000Source | 6,698,000Source | 5,086,000Source | 203,000Source | 190,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 19,745,000Source | — | 17,362,000Source | — | — | 19,843,000Source | — | — | 17,734,000Source | — | — | — |
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 578,000Source | 543,000Source | — | 126,000Source |
| Long-term Debt, Current MaturitiesUSD | 930,000Source | 773,000Source | 954,000Source | 773,000Source | 773,000Source | 947,000Source | 773,000Source | 773,000Source | 954,000Source | 773,000Source | — | 98,178,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | — | 96,336,000Source | — | 110,528,000Source | 92,085,000Source | — | 105,545,000Source | 88,057,000Source | — | 100,819,000Source | 98,900,000Source | 0Source |
| Long-term Debt | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | — | -99,563,000Source | -114,679,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 1,981,000Source | 1,993,000Source | 8,027,000Source | 8,859,000Source | 13,285,000Source | 17,884,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 2,392,000Source | 2,419,000Source | 10,158,000Source | 6,201,000Source | 3,612,000Source | 2,608,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -1,968,000Source | 1,663,000Source | -7,688,000Source | -862,000Source | 14,811,000Source | 5,960,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 2,256,000Source | 3,628,000Source | -1,670,000Source | -6,676,000Source | 16,038,000Source | 9,343,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | -119,000Source | 156,000Source | 254,000Source | -6,324,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | 1,762,000Source | -613,000Source | -206,000Source | -217,000Source | -17,441,000Source | -24,399,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -1,737,000Source | -3,422,000Source | -6,415,000Source | -17,921,000Source | -4,811,000Source | 81,768,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 1,737,000Source | 3,422,000Source | 13,415,000Source | — | — | 26,226,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | 1,156,000Source | 589,000Source | 1,270,000Source | 152,000Source | 274,000Source | 789,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -1,388,000Source | 1,093,000Source | 6,424,000Source | 7,509,000Source | 39,700,000Source | -57,021,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | — | — | — | — | — | — | — | — | -1,365,000Source | — | — | — |
| Repayments of Long-term DebtUSD | — | — | — | — | — | — | — | — | — | 0Source | 123,690,000Source | 86,411,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -1,363,000Source | -2,942,000Source | -197,000Source | -10,629,000Source | 17,448,000Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 5,417,000Source | 3,073,000Source | 17,469,000Source | 9,455,000Source | 18,856,000Source | 5,520,000Source | 8,265,000Source | 8,462,000Source | 19,091,000Source | 1,643,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 265,000Source | 628,000Source | 1,907,000Source | 2,730,000Source | 31,024,000Source | 16,888,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 46,000Source | 72,000Source | 23,000Source | 441,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | — | — | 3,372,000Source | — | 2,419,000Source | 10,158,000Source | 6,201,000Source | 3,612,000Source | 2,608,000Source |
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | 1,382,000Source |
| Capitalized Computer Software, AmortizationUSD | — | — | — | — | — | — | — | — | — | 500,000Source | 500,000Source | 500,000Source |
| DepreciationUSD | — | — | — | — | — | — | 1,981,000Source | 1,993,000Source | 8,027,000Source | — | — | — |
| Disposal Group, Not Discontinued Operation, Gain (Loss) on DisposalUSD | — | — | — | — | — | — | — | — | — | — | 0Source | -336,000Source |
| Gain (Loss) on Disposition of Other AssetsUSD | — | — | — | — | — | — | — | — | -7,776,000Source | — | — | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | — | — | — | -18,000Source | -38,000Source | -152,000Source |
| Gain (Loss) on Termination of LeaseUSD | — | — | — | — | — | — | — | — | 2,642,000Source | — | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | — | — | — | 0Source | -23,741,000Source | — |
| GoodwillUSD | — | — | 13,881,000Source | 13,881,000Source | 13,881,000Source | 13,881,000Source | 13,881,000Source | 13,881,000Source | 13,881,000Source | 13,881,000Source | 13,881,000Source | 13,881,000Source |
| Goodwill and Intangible Asset ImpairmentUSD | — | — | — | — | — | — | — | — | — | 0Source | 1,300,000Source | 78,146,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | — | — | — | 20,035,000Source |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)USD | — | — | — | — | — | — | — | — | — | — | — | 14,150,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | -14,769,000Source | 14,785,000Source | — | -6,571,000Source | — | — | -38,717,000Source | — | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | 14,785,000Source | — | — | — | -16,230,000Source | — | 9,331,000Source | -64,236,000Source | -63,524,000Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | 847,000Source | — | — | — | 0Source | — | 2,682,000Source | -35,327,000Source | -51,155,000Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | — | — | 0Source | 847,000Source | — | 0Source | — | — | 0Source | — | — | — |
| Income Tax Expense (Benefit)USD | — | — | -8,000Source | 217,000Source | — | 43,000Source | 333,000Source | -25,000Source | 43,000Source | 183,000Source | 308,000Source | -5,945,000Source |
| Inventory Write-downUSD | — | — | — | — | — | — | — | 1,217,000Source | — | 800,000Source | 4,900,000Source | — |
| Investment Income, InterestUSD | — | — | — | — | — | — | 58,000Source | 15,000Source | 333,000Source | — | 68,000Source | 81,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -14,769,000Source | 15,632,000Source | — | -6,571,000Source | -9,991,000Source | -16,230,000Source | -38,717,000Source | 12,013,000Source | -99,563,000Source | -114,679,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -17,379,000Source | 15,632,000Source | — | -8,703,000Source | -10,913,000Source | -16,230,000Source | -44,359,000Source | — | — | — |
| Operating ExpensesUSD | — | — | — | 12,789,000Source | — | 13,043,000Source | — | 16,971,000Source | — | 50,694,000Source | 49,781,000Source | 109,018,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 333,000Source | -814,000Source | — | -304,000Source | 110,000Source | -203,000Source | -3,000Source | -3,052,000Source | -1,159,000Source | 641,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 0Source | 1,000Source | 23,850,000Source | 0Source | 4,822,000Source | 0Source |
| Proceeds from Issuance of Long-term DebtUSD | — | — | — | — | — | — | — | — | — | — | 150,000,000Source | 20,000,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | 0Source | 0Source | 724,000Source | — | — |
| Financing Receivable, Credit Loss, Expense (Reversal)USD | — | — | — | — | — | — | — | -11,000Source | — | 263,000Source | 163,000Source | — |
| Restructuring CostsUSD | — | — | — | — | — | — | — | — | — | — | 4,184,000Source | 8,961,000Source |
| Restructuring Costs and Asset Impairment ChargesUSD | — | — | — | — | — | — | — | — | — | 1,402,000Source | 640,000Source | 5,185,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | 35,154,000Source | 35,704,000Source | — | 32,564,000Source | 31,109,000Source | 24,705,000Source | 128,867,000Source | 128,261,000Source | 103,269,000Source | 185,786,000Source |
| Unrealized Gain (Loss) on DerivativesUSD | — | — | — | — | — | — | -375,000Source | 900,000Source | 409,000Source | 39,500,000Source | — | — |
| Share-based Payment Arrangement, Expensed and Capitalized, Amount | — | — | — | — | — | —Source | — | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of RevenueUSD | — | — | 25,309,000Source | 23,810,000Source | 21,480,000Source | 20,193,000Source | 23,318,000Source | 19,318,000Source | 88,569,000Source | 86,411,000Source | 75,284,000Source | 135,416,000Source |
| Selling, General and Administrative ExpenseUSD | — | — | 10,093,000Source | 9,848,000Source | 11,119,000Source | 9,342,000Source | 8,895,000Source | 14,785,000Source | 44,046,000Source | 40,463,000Source | 38,969,000Source | 46,127,000Source |
| Operating Income (Loss)USD | — | — | -9,029,000Source | -895,000Source | -1,959,000Source | -1,483,000Source | -3,067,000Source | -11,584,000Source | -17,245,000Source | -8,844,000Source | -21,796,000Source | -58,648,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 333,000Source | -814,000Source | -304,000Source | -967,000Source | 110,000Source | -203,000Source | -3,000Source | -3,052,000Source | -1,159,000Source | 641,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -14,777,000Source | 15,002,000Source | -6,528,000Source | 14,177,000Source | -9,658,000Source | -16,255,000Source | -38,674,000Source | 9,514,000Source | -63,928,000Source | -69,469,000Source |
| Income Tax Expense (Benefit)USD | — | — | -8,000Source | 217,000Source | 43,000Source | -65,000Source | 333,000Source | -25,000Source | 43,000Source | 183,000Source | 308,000Source | -5,945,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -14,769,000Source | 15,632,000Source | -6,571,000Source | 14,218,000Source | -9,991,000Source | -16,230,000Source | -38,717,000Source | 12,013,000Source | -99,563,000Source | -114,679,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.47Source | 0.51Source | -0.25Source | 0.47Source | -0.29Source | -0.53Source | -1.27Source | 0.4Source | -3.32Source | -3.9Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.47Source | 0.42Source | -0.25Source | 0.39Source | -0.29Source | -0.53Source | -1.27Source | 0.32Source | -3.32Source | -3.9Source |
| Total Revenue | — | — | — | — | — | — | — | — | — | — | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 37,020,570Source | 30,487,596Source | 34,360,657Source | 30,458,032Source | 37,402,912Source | 30,855,742Source | 34,818,906Source | 30,474,000Source | 29,958,000Source | 29,466,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 37,020,570Source | 36,608,904Source | 34,360,657Source | 36,419,103Source | 37,402,912Source | 30,855,742Source | 34,818,906Source | 36,658,000Source | 29,958,000Source | 29,466,000Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | 1,382,000Source |
| Capitalized Computer Software, AmortizationUSD | — | — | — | — | — | — | — | — | — | 500,000Source | 500,000Source | 500,000Source |
| Cost, Depreciation and AmortizationUSD | — | — | — | — | — | — | — | — | — | — | — | 10,757,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 162,000Source | 27,000Source | 54,000Source | 379,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | 2,076,000Source | 2,006,000Source | 2,044,000Source | 1,987,000Source | — | 1,993,000Source | — | 8,000,000Source | 10,300,000Source | 9,300,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | — | — | — | 20,035,000Source |
| Gross ProfitUSD | — | — | 9,845,000Source | 11,894,000Source | 11,084,000Source | 9,957,000Source | 7,791,000Source | 5,387,000Source | 40,298,000Source | 41,850,000Source | 27,985,000Source | 50,370,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | -14,769,000Source | 14,785,000Source | -6,571,000Source | 14,242,000Source | — | — | -38,717,000Source | — | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | 14,785,000Source | — | 14,242,000Source | — | -16,230,000Source | — | 9,331,000Source | -64,236,000Source | -63,524,000Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | — | — | -0.47Source | 0.48Source | -0.25Source | 0.47Source | — | -0.53Source | -1.27Source | 0.31Source | -2.14Source | -2.16Source |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | — | — | -0.47Source | 0.4Source | -0.25Source | 0.39Source | — | -0.53Source | -1.27Source | 0.25Source | -2.14Source | -2.16Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | 847,000Source | — | -24,000Source | — | 0Source | — | 2,682,000Source | -35,327,000Source | -51,155,000Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | — | — | 0Source | 847,000Source | 0Source | -24,000Source | — | — | 0Source | — | — | — |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 17,649,000Source | 17,357,000Source |
| Interest Expense, DebtUSD | — | — | 5,481,000Source | 4,289,000Source | — | — | 6,384,000Source | 5,383,000Source | 22,168,000Source | — | — | — |
| Investment Income, InterestUSD | — | — | — | — | — | — | 58,000Source | 15,000Source | 333,000Source | — | 68,000Source | 81,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -17,379,000Source | 15,632,000Source | -8,703,000Source | 14,218,000Source | -10,913,000Source | -16,230,000Source | -44,359,000Source | — | — | — |
| Operating ExpensesUSD | — | — | — | 12,789,000Source | 13,043,000Source | 11,440,000Source | — | 16,971,000Source | — | 50,694,000Source | 49,781,000Source | 109,018,000Source |
| Preferred Stock Dividends, Income Statement ImpactUSD | — | — | 2,466,000Source | 0Source | — | — | 874,000Source | 0Source | 3,318,000Source | — | — | — |
| Research and Development ExpenseUSD | — | — | 2,045,000Source | 2,170,000Source | 1,924,000Source | 2,098,000Source | 1,963,000Source | 2,186,000Source | 8,258,000Source | 8,575,000Source | 8,736,000Source | 7,841,000Source |
| Restructuring CostsUSD | — | — | — | — | — | — | — | — | — | — | 4,184,000Source | 8,961,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | 35,154,000Source | 35,704,000Source | 32,564,000Source | 30,150,000Source | 31,109,000Source | 24,705,000Source | 128,867,000Source | 128,261,000Source | 103,269,000Source | 185,786,000Source |
| Share-based Payment Arrangement, Expensed and Capitalized, Amount | — | — | — | — | —Source | —Source | — | —Source | — | — | — | — |
Filing attachments
ny20082863x1_ex107.htm · PREM14A · 2026-10-30
Exhibit 107 Calculation of Filing Fee Tables Schedule 14A (Form Type) Lifecore Biomedical, Inc. ( Exact Name of Registrant as Specified in Its Charter ) Table 1: Transaction Valuation Note # Proposed Fee rate Amount of Filing Fee Maximum Aggregate Value of Transaction ──────────────────────────────────────────────────────────────…
Read attachment ↗ef20082009_ex99-1.htm · 8-K · 2026-09-28
Exhibit 99.1 Lifecore Biomedical to be Acquired by Webster Equity Partners Lifecore Common Stockholders to Receive $6.28 per Share in Cash at Closing, Representing a 49.5% Premium Lifecore Series A Preferred Stockholders Will Receive Required “Conversion Amount” per Share in Cash at Closing Both Common Stockholders and Series A Preferred Stockholders Will Receive Contingent Value Rights (CVRs) for Up to $160 Million in Aggregate Cash Payments Contingent Upon Achieving Performance M…
Read attachment ↗ef20082009_ex99-2.htm · 8-K · 2026-09-28
Exhibit 99.2 Email from CEO of Lifecore Biomedical, Inc. September 28, 2026 Lifecore Team, I’m reaching out to share an exciting and important update about our company and the future we are building together. Lifecore Biomedical has entered into a merger agreement to be acquired by Webster Equity Partners in a transaction valued at up to approximately $663.7 million. Under the merger agreement, holders of common stock will receive $6.28 per share in cash at closing. Holders of common stock a…
Read attachment ↗ex992_lfcrpresentation.htm · 8-K · 2026-08-05
EX-99.2 3 ex992_lfcrpresentation.htm EX-99.2 ex992_lfcrpresentation Building a high-performing, growth-focused, sterile injectable CDMO August 2026 Exhibit 99.2 2 Important Information Regarding Forward-Looking Statements This presentation contains forward-looking statements regarding future events and our future results that are subject to the safe harbor created under the Private Securities Litigation Reform Act of 1995 and other safe harbors under the Securities Act of 1933 and the Secu…
Read attachment ↗ex992_lfcrpresentation.htm · 8-K · 2026-05-06
EX-99.2 3 ex992_lfcrpresentation.htm EX-99.2 ex992_lfcrpresentation Building a high-performing, growth-focused, sterile injectable CDMO May 2026 2 Important Information Regarding Forward-Looking Statements This presentation contains forward-looking statements regarding future events and our future results that are subject to the safe harbor created under the Private Securities Litigation Reform Act of 1995 and other safe harbors under the Securities Act of 1933 and the Securities Exchange …
Read attachment ↗ex992_lfcrpresentation.htm · 8-K · 2026-03-16
EX-99.2 3 ex992_lfcrpresentation.htm EX-99.2 ex992_lfcrpresentation Building a high-performing, growth-focused, sterile injectable CDMO March 2026 2 Fiscal Year Change On August 1, 2025, our Board of Directors approved a change in the Company’s fiscal year that ended on the last Sunday of May to a fiscal year that corresponds with the calendar year, ending on December 31st, effective for the fiscal period beginning May 26, 2025, and ending December 31, 2025 (the “Fiscal Year Change”). The …
Read attachment ↗